Edition:
United Kingdom

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.79USD
18 Apr 2019
Change (% chg)

$-0.03 (-0.79%)
Prev Close
$3.82
Open
$3.83
Day's High
$3.83
Day's Low
$3.76
Volume
11,796
Avg. Vol
15,773
52-wk High
$5.34
52-wk Low
$2.95

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Irit Arbel

58 2014 Independent Chairman of the Board

Chaim Lebovits

47 2015 President, Chief Executive Officer

Eyal Rubin

43 2017 Chief Financial Officer, Treasurer

Ralph Kern

61 2017 Chief Operating Officer and Chief Medical Officer

Uri Yablonka

42 2017 Executive Vice President, Chief Business Officer, Director